Results 81 to 90 of about 52,548 (162)

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination. [PDF]

iScience
Abdullahi A, Morse RB, Kin Cheng MT, Ige F, Onyemata J, Edun M, Kramna A, Sievers B, Turner S, Wisso H, Jonathan E, Balogun O, Salako A, Abdulazeez-Oha H, James A, Musa A, Oluwaseun O, Iwalokun B, Ezechi O, Anzaku A, Okpokoro E, Osawe S, Nwikue G, Kida IM, Musa BM, Murtala HA, Meng B, Rosenzweig L, Aliyu SH, Smith D, MacAry P, Doffinger R, Więcek W, Salako B, Tan CW, Abimiku A, Gupta RK.   +36 more
europepmc   +1 more source

Climatic Influence on COVID-19: Investigating the Role of Temperature and Humidity in the Spread of the Omicron Variant. [PDF]

Geohealth
López L, Fontal A, Alfaro B, Rodó X.
europepmc   +1 more source

Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2 Omicron JN.1 and LP.8.1 Subvariant Lineage Strains with Homologous and Heterologous Matched Sera in Clinically Relevant Samples. [PDF]

Microorganisms
Cai Z, Kalkeri R, Haner B, Wang M, Skonieczny P, Osman B, Dent D, Silva D, Auerbach K, Faust E, Feng SL, Cai MR, Zhu M, Cloney-Clark S, Plested JS.   +14 more
europepmc   +1 more source

D614G reshapes allosteric networks and opening mechanisms of SARS-CoV-2 spikes. [PDF]

Proc Natl Acad Sci U S A
Kearns FL, Bogetti AT, Calvó-Tusell C, Braza MKE, Casalino L, Gramm AJ, Braet S, Rosenfeld MA, Rajapaksha H, Barker B, Anand G, Chong LT, Ahn SH, Amaro RE.   +13 more
europepmc   +1 more source

Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape. [PDF]

PLoS Pathog
Bu F, Saxena D, Turner-Hubbard H, Delaney A, Batra L, Fricke C, Moye S, Verma A, Perlman S, Bhandari J, Liu B, Ye G, Zheng J, Li F.   +13 more
europepmc   +1 more source

The Shifting Paradigm of Monoclonal Antibodies in COVID-19 Management: From Early Triumphs to Viral Resistance and Future Perspectives. [PDF]

Antibodies (Basel)
Ferrara F, De Berardinis F, Scognamiglio M, Zovi A.   +3 more
europepmc   +1 more source

Broadly Protective Antibody-Like Vaccines Against Highly Pathogenic Coronaviruses. [PDF]

J Med Virol
Helal A, Aljehani ND, Ghazwani A, Alsulaiman RM, Alyami F, Abdulaal WH, Alsharef A, Alghanmi M, Zawawi A, Azhari AA, Almehmadi A, Balula J, Altorki T, Alhabbab RY, Khan MY, Alluhaybi K, Alnami A, Neamatallah T, Abujamel TS, Alfaleh MA, Hashem AM.   +20 more
europepmc   +1 more source

On the Use of Immunoglobulins for Pre-exposure Prophylaxis Against COVID-19 in Immunocompromised Patients. [PDF]

Infect Drug Resist
Focosi D, Franchini M, Casadevall A.
europepmc   +1 more source

Omicron: The tsunami??

Indian Journal of Health Sciences and Biomedical Research (KLEU), 2022
openaire   +2 more sources

Vaccine effectiveness against COVID-19 in-hospital mortality in people living with HIV across SARS-CoV-2 variant waves: Analyses of data from the WHO Global Clinical Platform. [PDF]

Medicine (Baltimore)
Inzaule S, Silva R, Ford N, Thwin SS, Waasila J, Zumla A, Doherty M, Diaz J, Bertagnolio S.   +8 more
europepmc   +1 more source